Tumor vaccination with CXCL9/10-DC induced a statistically significant elevation in the concentrations of CXCL9 and CXCL10 within the TME at 24 h, surpassing levels observed with PBS control and Mock-DC (Figure S3B). Here, CXCL10 is linked to neoplasm.